跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Chang-Sze-Long D'Lumrid Capsule - NPRA Drug Approval Details
Approvals
/
NPRA
/
Chang-Sze-Long D'Lumrid Capsule
Approved
STANDARD
Chang-Sze-Long D'Lumrid Capsule
NANG HIN MEDICAL SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
929989badddbf8e9
Company
NANG HIN MEDICAL SDN. BHD.
Type
Standard
Approval Details
Approval Id
929989badddbf8e9
Drug Approval Npra Name
Chang-Sze-Long D'Lumrid Capsule
Product Name
Chang-Sze-Long D'Lumrid Capsule
Registration Number
MAL08061668TC
Holder Company Name
NANG HIN MEDICAL SDN. BHD.
Holder Address
NO. 24A & 24B, JALAN BPU 4, BANDAR PUCHONG UTAMA, 47100 PUCHONG MALAYSIA
Holder Phone
03-58826113, 03-58826123
Manufacturer Company Name
QIS RESEARCH LABORATORY SDN. BHD.
Manufacturer Address
LOT 11995, BATU 2 JALAN KAPAR 41400 KLANG MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL08061668TC
Version
1751614600
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
929989badddbf8e9
Type
Standard
Source
Official Source
Back to NPRA Approvals